Regeneron Pharmaceuticals (REGN) has a market capitalization of $65.7B, based on 108.8M shares at a price of $603.89 (down 0.2% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $602.64 | 20,148,700 | 108,802,005 | $65,568,440,293.20 |
March 2025 | $634.23 | 20,912,300 | 113,800,000 | $72,175,374,000.00 |
February 2025 | $698.74 | 17,887,000 | 113,800,000 | $79,516,612,000.00 |
January 2025 | $672.12 | 17,766,800 | 113,800,000 | $76,486,834,940.00 |
December 2024 | $711.42 | 18,051,400 | 113,800,000 | $80,959,118,040.00 |
November 2024 | $749.26 | 16,783,800 | 113,800,000 | $85,265,457,980.00 |
October 2024 | $837.12 | 17,457,700 | 113,800,000 | $95,264,733,960.00 |
September 2024 | $1,049.89 | 12,689,200 | 116,200,000 | $121,997,310,960.00 |
August 2024 | $1,183.17 | 10,420,300 | 116,200,000 | $137,484,284,280.00 |
July 2024 | $1,077.80 | 8,543,300 | 116,200,000 | $125,240,917,760.00 |
June 2024 | $1,049.68 | 9,310,500 | 115,400,000 | $121,133,198,940.00 |
May 2024 | $978.90 | 9,455,700 | 115,400,000 | $112,965,290,800.00 |
April 2024 | $889.52 | 10,148,700 | 115,400,000 | $102,650,250,260.00 |
March 2024 | $961.25 | 8,523,900 | 115,100,000 | $110,640,415,970.00 |
February 2024 | $964.85 | 10,253,800 | 115,100,000 | $111,054,246,510.00 |
January 2024 | $941.57 | 11,852,200 | 115,100,000 | $108,374,707,000.00 |
December 2023 | $877.16 | 12,741,300 | 113,800,000 | $99,821,126,640.00 |
November 2023 | $822.75 | 11,110,200 | 113,800,000 | $93,629,257,260.00 |
October 2023 | $778.89 | 8,722,000 | 113,800,000 | $88,637,579,580.00 |
September 2023 | $821.90 | 8,085,100 | 113,400,000 | $93,203,890,920.00 |
August 2023 | $825.43 | 11,808,600 | 113,400,000 | $93,603,682,620.00 |
July 2023 | $740.96 | 13,082,500 | 113,400,000 | $84,024,614,520.00 |
June 2023 | $717.62 | 14,710,600 | 113,900,000 | $81,736,667,420.00 |
May 2023 | $734.62 | 12,554,000 | 113,900,000 | $83,672,762,400.00 |
April 2023 | $800.76 | 8,863,700 | 113,900,000 | $91,206,677,900.00 |
